First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer

Camille Travert, Pascale Tomasini, Arnaud Jeanson, Laurent Greillier, Fabrice Barlesi

Research output: Contribution to journal › Comment/debate

4 Citations (Scopus)

Original language	English
Pages (from-to)	2514-2516
Number of pages	3
Journal	Translational Cancer Research
Volume	8
Issue number	7
DOIs	https://doi.org/10.21037/tcr.2019.05.20
Publication status	Published - 1 Jan 2019
Externally published	Yes

Access to Document

@article{40cce59ff83a41e1bec10de1d1d922bc,

title = "First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer",

author = "Camille Travert and Pascale Tomasini and Arnaud Jeanson and Laurent Greillier and Fabrice Barlesi",

year = "2019",

month = jan,

day = "1",

doi = "10.21037/tcr.2019.05.20",

language = "English",

volume = "8",

pages = "2514--2516",

journal = "Translational Cancer Research",

issn = "2218-676X",

number = "7",

}

TY - JOUR

T1 - First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer

AU - Travert, Camille

AU - Tomasini, Pascale

AU - Jeanson, Arnaud

AU - Greillier, Laurent

AU - Barlesi, Fabrice

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85076200656&partnerID=8YFLogxK

U2 - 10.21037/tcr.2019.05.20

DO - 10.21037/tcr.2019.05.20

M3 - Comment/debate

AN - SCOPUS:85076200656

SN - 2218-676X

VL - 8

SP - 2514

EP - 2516

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 7

ER -